Results for tag: "Praxbind"

Praxbind is a hematological drug used to reverse the anticoagulant effects of Pradaxa (dabigatran etexilate). It is a direct thrombin inhibitor, which works by binding to thrombin and blocking its activity. This helps to restore normal blood clotting and reduce the risk of bleeding. Praxbind is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to reduce the risk of stroke in patients with atrial fibrillation. Praxbind is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2015. It is currently marketed by Boehringer Ingelheim, a German pharmaceutical company. Other companies involved in the market include Pfizer, Sanofi, and Bristol-Myers Squibb. Show Less Read more